Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00253448 · ClinicalTrials.gov registry record · Phase 2
Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
A Phase 2 study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT00253448 is a Phase 2 study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 35 participants.
The verdict
NCT00253448, a Phase 2 study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving stereotactic radiosurgery together with radiation therapy may kill more tumor cells. PURPOSE: This phase II trial is studying how well giving stereotactic radiosurgery together with radiation therapy works in treating patients with glioblastoma multiforme.
Interventions
- RADIATION radiation therapy
- RADIATION stereotactic radiosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2002-12 |
| Est. Completion | 2011-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00253448
The ClinicalTrials.gov registry entry for NCT00253448 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which radiation therapy is the first listed.
NCT00253448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00253448 about?
NCT00253448 is a clinical study titled "Stereotactic Radiosurgery and Radiation Therapy in Treating Patients With Glioblastoma Multiforme". RATIONALE: Stereotactic radiosurgery may be able to send x-rays directly to the tumor and cause less damage to normal tissue. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving stereotactic radiosurgery together with radiation therapy may kill more tumor cells. PURPOSE: This phas...
What is the current status of trial NCT00253448?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2002-12. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00253448?
The interventions under investigation include: radiation therapy (RADIATION), stereotactic radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT00253448?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.